Global AI-assisted Drug Design (AIDD) Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
The global AI-assisted Drug Design (AIDD) market size is projected to grow from US$ 1336.6 million in 2022 to US$ 9237.4 million in 2029; it is expected to grow at a CAGR of 31.8% from 2023 to 2029.
United States market for AI-assisted Drug Design (AIDD) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for AI-assisted Drug Design (AIDD) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for AI-assisted Drug Design (AIDD) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key AI-assisted Drug Design (AIDD) players cover IBM, Exscientia, Google(Alphabet), Microsoft, Atomwise, Schrodinger, Aitia, Insilico Medicine and NVIDIA, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Artificial intelligence (AI) has the potential to revolutionize the drug discovery process,
offering improved efficiency, accuracy, and speed.
LPI (LP Information)' newest research report, the “AI-assisted Drug Design (AIDD) Industry Forecast” looks at past sales and reviews total world AI-assisted Drug Design (AIDD) sales in 2022, providing a comprehensive analysis by region and market sector of projected AI-assisted Drug Design (AIDD) sales for 2023 through 2029. With AI-assisted Drug Design (AIDD) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world AI-assisted Drug Design (AIDD) industry.
This Insight Report provides a comprehensive analysis of the global AI-assisted Drug Design (AIDD) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on AI-assisted Drug Design (AIDD) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global AI-assisted Drug Design (AIDD) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for AI-assisted Drug Design (AIDD) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global AI-assisted Drug Design (AIDD).
This report presents a comprehensive overview, market shares, and growth opportunities of AI-assisted Drug Design (AIDD) market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
The global AI-assisted Drug Design (AIDD) market size is projected to grow from US$ 1336.6 million in 2022 to US$ 9237.4 million in 2029; it is expected to grow at a CAGR of 31.8% from 2023 to 2029.
United States market for AI-assisted Drug Design (AIDD) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for AI-assisted Drug Design (AIDD) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for AI-assisted Drug Design (AIDD) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key AI-assisted Drug Design (AIDD) players cover IBM, Exscientia, Google(Alphabet), Microsoft, Atomwise, Schrodinger, Aitia, Insilico Medicine and NVIDIA, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Artificial intelligence (AI) has the potential to revolutionize the drug discovery process,
offering improved efficiency, accuracy, and speed.
LPI (LP Information)' newest research report, the “AI-assisted Drug Design (AIDD) Industry Forecast” looks at past sales and reviews total world AI-assisted Drug Design (AIDD) sales in 2022, providing a comprehensive analysis by region and market sector of projected AI-assisted Drug Design (AIDD) sales for 2023 through 2029. With AI-assisted Drug Design (AIDD) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world AI-assisted Drug Design (AIDD) industry.
This Insight Report provides a comprehensive analysis of the global AI-assisted Drug Design (AIDD) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on AI-assisted Drug Design (AIDD) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global AI-assisted Drug Design (AIDD) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for AI-assisted Drug Design (AIDD) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global AI-assisted Drug Design (AIDD).
This report presents a comprehensive overview, market shares, and growth opportunities of AI-assisted Drug Design (AIDD) market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Hardware
- Software
- Service
- Early Drug Discovery
- Preclinical Phase
- Clinical Phase
- Regulatory Approval
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- IBM
- Exscientia
- Google(Alphabet)
- Microsoft
- Atomwise
- Schrodinger
- Aitia
- Insilico Medicine
- NVIDIA
- XtalPi
- BPGbio
- Owkin
- CytoReason
- Deep Genomics
- Cloud Pharmaceuticals
- BenevolentAI
- Cyclica
- Verge Genomics
- Valo Health
- Envisagenics
- Euretos
- BioAge Labs
- Iktos
- BioSymetrics
- Evaxion Biotech
- Aria Pharmaceuticals
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global AI-assisted Drug Design (AIDD) Market Size 2018-2029
2.1.2 AI-assisted Drug Design (AIDD) Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 AI-assisted Drug Design (AIDD) Segment by Type
2.2.1 Hardware
2.2.2 Software
2.2.3 Service
2.3 AI-assisted Drug Design (AIDD) Market Size by Type
2.3.1 AI-assisted Drug Design (AIDD) Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global AI-assisted Drug Design (AIDD) Market Size Market Share by Type (2018-2023)
2.4 AI-assisted Drug Design (AIDD) Segment by Application
2.4.1 Early Drug Discovery
2.4.2 Preclinical Phase
2.4.3 Clinical Phase
2.4.4 Regulatory Approval
2.5 AI-assisted Drug Design (AIDD) Market Size by Application
2.5.1 AI-assisted Drug Design (AIDD) Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global AI-assisted Drug Design (AIDD) Market Size Market Share by Application (2018-2023)
3 AI-ASSISTED DRUG DESIGN (AIDD) MARKET SIZE BY PLAYER
3.1 AI-assisted Drug Design (AIDD) Market Size Market Share by Players
3.1.1 Global AI-assisted Drug Design (AIDD) Revenue by Players (2018-2023)
3.1.2 Global AI-assisted Drug Design (AIDD) Revenue Market Share by Players (2018-2023)
3.2 Global AI-assisted Drug Design (AIDD) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AI-ASSISTED DRUG DESIGN (AIDD) BY REGIONS
4.1 AI-assisted Drug Design (AIDD) Market Size by Regions (2018-2023)
4.2 Americas AI-assisted Drug Design (AIDD) Market Size Growth (2018-2023)
4.3 APAC AI-assisted Drug Design (AIDD) Market Size Growth (2018-2023)
4.4 Europe AI-assisted Drug Design (AIDD) Market Size Growth (2018-2023)
4.5 Middle East & Africa AI-assisted Drug Design (AIDD) Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas AI-assisted Drug Design (AIDD) Market Size by Country (2018-2023)
5.2 Americas AI-assisted Drug Design (AIDD) Market Size by Type (2018-2023)
5.3 Americas AI-assisted Drug Design (AIDD) Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC AI-assisted Drug Design (AIDD) Market Size by Region (2018-2023)
6.2 APAC AI-assisted Drug Design (AIDD) Market Size by Type (2018-2023)
6.3 APAC AI-assisted Drug Design (AIDD) Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe AI-assisted Drug Design (AIDD) by Country (2018-2023)
7.2 Europe AI-assisted Drug Design (AIDD) Market Size by Type (2018-2023)
7.3 Europe AI-assisted Drug Design (AIDD) Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa AI-assisted Drug Design (AIDD) by Region (2018-2023)
8.2 Middle East & Africa AI-assisted Drug Design (AIDD) Market Size by Type (2018-2023)
8.3 Middle East & Africa AI-assisted Drug Design (AIDD) Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL AI-ASSISTED DRUG DESIGN (AIDD) MARKET FORECAST
10.1 Global AI-assisted Drug Design (AIDD) Forecast by Regions (2024-2029)
10.1.1 Global AI-assisted Drug Design (AIDD) Forecast by Regions (2024-2029)
10.1.2 Americas AI-assisted Drug Design (AIDD) Forecast
10.1.3 APAC AI-assisted Drug Design (AIDD) Forecast
10.1.4 Europe AI-assisted Drug Design (AIDD) Forecast
10.1.5 Middle East & Africa AI-assisted Drug Design (AIDD) Forecast
10.2 Americas AI-assisted Drug Design (AIDD) Forecast by Country (2024-2029)
10.2.1 United States AI-assisted Drug Design (AIDD) Market Forecast
10.2.2 Canada AI-assisted Drug Design (AIDD) Market Forecast
10.2.3 Mexico AI-assisted Drug Design (AIDD) Market Forecast
10.2.4 Brazil AI-assisted Drug Design (AIDD) Market Forecast
10.3 APAC AI-assisted Drug Design (AIDD) Forecast by Region (2024-2029)
10.3.1 China AI-assisted Drug Design (AIDD) Market Forecast
10.3.2 Japan AI-assisted Drug Design (AIDD) Market Forecast
10.3.3 Korea AI-assisted Drug Design (AIDD) Market Forecast
10.3.4 Southeast Asia AI-assisted Drug Design (AIDD) Market Forecast
10.3.5 India AI-assisted Drug Design (AIDD) Market Forecast
10.3.6 Australia AI-assisted Drug Design (AIDD) Market Forecast
10.4 Europe AI-assisted Drug Design (AIDD) Forecast by Country (2024-2029)
10.4.1 Germany AI-assisted Drug Design (AIDD) Market Forecast
10.4.2 France AI-assisted Drug Design (AIDD) Market Forecast
10.4.3 UK AI-assisted Drug Design (AIDD) Market Forecast
10.4.4 Italy AI-assisted Drug Design (AIDD) Market Forecast
10.4.5 Russia AI-assisted Drug Design (AIDD) Market Forecast
10.5 Middle East & Africa AI-assisted Drug Design (AIDD) Forecast by Region (2024-2029)
10.5.1 Egypt AI-assisted Drug Design (AIDD) Market Forecast
10.5.2 South Africa AI-assisted Drug Design (AIDD) Market Forecast
10.5.3 Israel AI-assisted Drug Design (AIDD) Market Forecast
10.5.4 Turkey AI-assisted Drug Design (AIDD) Market Forecast
10.5.5 GCC Countries AI-assisted Drug Design (AIDD) Market Forecast
10.6 Global AI-assisted Drug Design (AIDD) Forecast by Type (2024-2029)
10.7 Global AI-assisted Drug Design (AIDD) Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 IBM
11.1.1 IBM Company Information
11.1.2 IBM AI-assisted Drug Design (AIDD) Product Offered
11.1.3 IBM AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 IBM Main Business Overview
11.1.5 IBM Latest Developments
11.2 Exscientia
11.2.1 Exscientia Company Information
11.2.2 Exscientia AI-assisted Drug Design (AIDD) Product Offered
11.2.3 Exscientia AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Exscientia Main Business Overview
11.2.5 Exscientia Latest Developments
11.3 Google(Alphabet)
11.3.1 Google(Alphabet) Company Information
11.3.2 Google(Alphabet) AI-assisted Drug Design (AIDD) Product Offered
11.3.3 Google(Alphabet) AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Google(Alphabet) Main Business Overview
11.3.5 Google(Alphabet) Latest Developments
11.4 Microsoft
11.4.1 Microsoft Company Information
11.4.2 Microsoft AI-assisted Drug Design (AIDD) Product Offered
11.4.3 Microsoft AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Microsoft Main Business Overview
11.4.5 Microsoft Latest Developments
11.5 Atomwise
11.5.1 Atomwise Company Information
11.5.2 Atomwise AI-assisted Drug Design (AIDD) Product Offered
11.5.3 Atomwise AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Atomwise Main Business Overview
11.5.5 Atomwise Latest Developments
11.6 Schrodinger
11.6.1 Schrodinger Company Information
11.6.2 Schrodinger AI-assisted Drug Design (AIDD) Product Offered
11.6.3 Schrodinger AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Schrodinger Main Business Overview
11.6.5 Schrodinger Latest Developments
11.7 Aitia
11.7.1 Aitia Company Information
11.7.2 Aitia AI-assisted Drug Design (AIDD) Product Offered
11.7.3 Aitia AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Aitia Main Business Overview
11.7.5 Aitia Latest Developments
11.8 Insilico Medicine
11.8.1 Insilico Medicine Company Information
11.8.2 Insilico Medicine AI-assisted Drug Design (AIDD) Product Offered
11.8.3 Insilico Medicine AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Insilico Medicine Main Business Overview
11.8.5 Insilico Medicine Latest Developments
11.9 NVIDIA
11.9.1 NVIDIA Company Information
11.9.2 NVIDIA AI-assisted Drug Design (AIDD) Product Offered
11.9.3 NVIDIA AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 NVIDIA Main Business Overview
11.9.5 NVIDIA Latest Developments
11.10 XtalPi
11.10.1 XtalPi Company Information
11.10.2 XtalPi AI-assisted Drug Design (AIDD) Product Offered
11.10.3 XtalPi AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 XtalPi Main Business Overview
11.10.5 XtalPi Latest Developments
11.11 BPGbio
11.11.1 BPGbio Company Information
11.11.2 BPGbio AI-assisted Drug Design (AIDD) Product Offered
11.11.3 BPGbio AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 BPGbio Main Business Overview
11.11.5 BPGbio Latest Developments
11.12 Owkin
11.12.1 Owkin Company Information
11.12.2 Owkin AI-assisted Drug Design (AIDD) Product Offered
11.12.3 Owkin AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Owkin Main Business Overview
11.12.5 Owkin Latest Developments
11.13 CytoReason
11.13.1 CytoReason Company Information
11.13.2 CytoReason AI-assisted Drug Design (AIDD) Product Offered
11.13.3 CytoReason AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 CytoReason Main Business Overview
11.13.5 CytoReason Latest Developments
11.14 Deep Genomics
11.14.1 Deep Genomics Company Information
11.14.2 Deep Genomics AI-assisted Drug Design (AIDD) Product Offered
11.14.3 Deep Genomics AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Deep Genomics Main Business Overview
11.14.5 Deep Genomics Latest Developments
11.15 Cloud Pharmaceuticals
11.15.1 Cloud Pharmaceuticals Company Information
11.15.2 Cloud Pharmaceuticals AI-assisted Drug Design (AIDD) Product Offered
11.15.3 Cloud Pharmaceuticals AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Cloud Pharmaceuticals Main Business Overview
11.15.5 Cloud Pharmaceuticals Latest Developments
11.16 BenevolentAI
11.16.1 BenevolentAI Company Information
11.16.2 BenevolentAI AI-assisted Drug Design (AIDD) Product Offered
11.16.3 BenevolentAI AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 BenevolentAI Main Business Overview
11.16.5 BenevolentAI Latest Developments
11.17 Cyclica
11.17.1 Cyclica Company Information
11.17.2 Cyclica AI-assisted Drug Design (AIDD) Product Offered
11.17.3 Cyclica AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Cyclica Main Business Overview
11.17.5 Cyclica Latest Developments
11.18 Verge Genomics
11.18.1 Verge Genomics Company Information
11.18.2 Verge Genomics AI-assisted Drug Design (AIDD) Product Offered
11.18.3 Verge Genomics AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Verge Genomics Main Business Overview
11.18.5 Verge Genomics Latest Developments
11.19 Valo Health
11.19.1 Valo Health Company Information
11.19.2 Valo Health AI-assisted Drug Design (AIDD) Product Offered
11.19.3 Valo Health AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 Valo Health Main Business Overview
11.19.5 Valo Health Latest Developments
11.20 Envisagenics
11.20.1 Envisagenics Company Information
11.20.2 Envisagenics AI-assisted Drug Design (AIDD) Product Offered
11.20.3 Envisagenics AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 Envisagenics Main Business Overview
11.20.5 Envisagenics Latest Developments
11.21 Euretos
11.21.1 Euretos Company Information
11.21.2 Euretos AI-assisted Drug Design (AIDD) Product Offered
11.21.3 Euretos AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
11.21.4 Euretos Main Business Overview
11.21.5 Euretos Latest Developments
11.22 BioAge Labs
11.22.1 BioAge Labs Company Information
11.22.2 BioAge Labs AI-assisted Drug Design (AIDD) Product Offered
11.22.3 BioAge Labs AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
11.22.4 BioAge Labs Main Business Overview
11.22.5 BioAge Labs Latest Developments
11.23 Iktos
11.23.1 Iktos Company Information
11.23.2 Iktos AI-assisted Drug Design (AIDD) Product Offered
11.23.3 Iktos AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
11.23.4 Iktos Main Business Overview
11.23.5 Iktos Latest Developments
11.24 BioSymetrics
11.24.1 BioSymetrics Company Information
11.24.2 BioSymetrics AI-assisted Drug Design (AIDD) Product Offered
11.24.3 BioSymetrics AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
11.24.4 BioSymetrics Main Business Overview
11.24.5 BioSymetrics Latest Developments
11.25 Evaxion Biotech
11.25.1 Evaxion Biotech Company Information
11.25.2 Evaxion Biotech AI-assisted Drug Design (AIDD) Product Offered
11.25.3 Evaxion Biotech AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
11.25.4 Evaxion Biotech Main Business Overview
11.25.5 Evaxion Biotech Latest Developments
11.26 Aria Pharmaceuticals
11.26.1 Aria Pharmaceuticals Company Information
11.26.2 Aria Pharmaceuticals AI-assisted Drug Design (AIDD) Product Offered
11.26.3 Aria Pharmaceuticals AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
11.26.4 Aria Pharmaceuticals Main Business Overview
11.26.5 Aria Pharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global AI-assisted Drug Design (AIDD) Market Size 2018-2029
2.1.2 AI-assisted Drug Design (AIDD) Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 AI-assisted Drug Design (AIDD) Segment by Type
2.2.1 Hardware
2.2.2 Software
2.2.3 Service
2.3 AI-assisted Drug Design (AIDD) Market Size by Type
2.3.1 AI-assisted Drug Design (AIDD) Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global AI-assisted Drug Design (AIDD) Market Size Market Share by Type (2018-2023)
2.4 AI-assisted Drug Design (AIDD) Segment by Application
2.4.1 Early Drug Discovery
2.4.2 Preclinical Phase
2.4.3 Clinical Phase
2.4.4 Regulatory Approval
2.5 AI-assisted Drug Design (AIDD) Market Size by Application
2.5.1 AI-assisted Drug Design (AIDD) Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global AI-assisted Drug Design (AIDD) Market Size Market Share by Application (2018-2023)
3 AI-ASSISTED DRUG DESIGN (AIDD) MARKET SIZE BY PLAYER
3.1 AI-assisted Drug Design (AIDD) Market Size Market Share by Players
3.1.1 Global AI-assisted Drug Design (AIDD) Revenue by Players (2018-2023)
3.1.2 Global AI-assisted Drug Design (AIDD) Revenue Market Share by Players (2018-2023)
3.2 Global AI-assisted Drug Design (AIDD) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AI-ASSISTED DRUG DESIGN (AIDD) BY REGIONS
4.1 AI-assisted Drug Design (AIDD) Market Size by Regions (2018-2023)
4.2 Americas AI-assisted Drug Design (AIDD) Market Size Growth (2018-2023)
4.3 APAC AI-assisted Drug Design (AIDD) Market Size Growth (2018-2023)
4.4 Europe AI-assisted Drug Design (AIDD) Market Size Growth (2018-2023)
4.5 Middle East & Africa AI-assisted Drug Design (AIDD) Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas AI-assisted Drug Design (AIDD) Market Size by Country (2018-2023)
5.2 Americas AI-assisted Drug Design (AIDD) Market Size by Type (2018-2023)
5.3 Americas AI-assisted Drug Design (AIDD) Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC AI-assisted Drug Design (AIDD) Market Size by Region (2018-2023)
6.2 APAC AI-assisted Drug Design (AIDD) Market Size by Type (2018-2023)
6.3 APAC AI-assisted Drug Design (AIDD) Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe AI-assisted Drug Design (AIDD) by Country (2018-2023)
7.2 Europe AI-assisted Drug Design (AIDD) Market Size by Type (2018-2023)
7.3 Europe AI-assisted Drug Design (AIDD) Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa AI-assisted Drug Design (AIDD) by Region (2018-2023)
8.2 Middle East & Africa AI-assisted Drug Design (AIDD) Market Size by Type (2018-2023)
8.3 Middle East & Africa AI-assisted Drug Design (AIDD) Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL AI-ASSISTED DRUG DESIGN (AIDD) MARKET FORECAST
10.1 Global AI-assisted Drug Design (AIDD) Forecast by Regions (2024-2029)
10.1.1 Global AI-assisted Drug Design (AIDD) Forecast by Regions (2024-2029)
10.1.2 Americas AI-assisted Drug Design (AIDD) Forecast
10.1.3 APAC AI-assisted Drug Design (AIDD) Forecast
10.1.4 Europe AI-assisted Drug Design (AIDD) Forecast
10.1.5 Middle East & Africa AI-assisted Drug Design (AIDD) Forecast
10.2 Americas AI-assisted Drug Design (AIDD) Forecast by Country (2024-2029)
10.2.1 United States AI-assisted Drug Design (AIDD) Market Forecast
10.2.2 Canada AI-assisted Drug Design (AIDD) Market Forecast
10.2.3 Mexico AI-assisted Drug Design (AIDD) Market Forecast
10.2.4 Brazil AI-assisted Drug Design (AIDD) Market Forecast
10.3 APAC AI-assisted Drug Design (AIDD) Forecast by Region (2024-2029)
10.3.1 China AI-assisted Drug Design (AIDD) Market Forecast
10.3.2 Japan AI-assisted Drug Design (AIDD) Market Forecast
10.3.3 Korea AI-assisted Drug Design (AIDD) Market Forecast
10.3.4 Southeast Asia AI-assisted Drug Design (AIDD) Market Forecast
10.3.5 India AI-assisted Drug Design (AIDD) Market Forecast
10.3.6 Australia AI-assisted Drug Design (AIDD) Market Forecast
10.4 Europe AI-assisted Drug Design (AIDD) Forecast by Country (2024-2029)
10.4.1 Germany AI-assisted Drug Design (AIDD) Market Forecast
10.4.2 France AI-assisted Drug Design (AIDD) Market Forecast
10.4.3 UK AI-assisted Drug Design (AIDD) Market Forecast
10.4.4 Italy AI-assisted Drug Design (AIDD) Market Forecast
10.4.5 Russia AI-assisted Drug Design (AIDD) Market Forecast
10.5 Middle East & Africa AI-assisted Drug Design (AIDD) Forecast by Region (2024-2029)
10.5.1 Egypt AI-assisted Drug Design (AIDD) Market Forecast
10.5.2 South Africa AI-assisted Drug Design (AIDD) Market Forecast
10.5.3 Israel AI-assisted Drug Design (AIDD) Market Forecast
10.5.4 Turkey AI-assisted Drug Design (AIDD) Market Forecast
10.5.5 GCC Countries AI-assisted Drug Design (AIDD) Market Forecast
10.6 Global AI-assisted Drug Design (AIDD) Forecast by Type (2024-2029)
10.7 Global AI-assisted Drug Design (AIDD) Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 IBM
11.1.1 IBM Company Information
11.1.2 IBM AI-assisted Drug Design (AIDD) Product Offered
11.1.3 IBM AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 IBM Main Business Overview
11.1.5 IBM Latest Developments
11.2 Exscientia
11.2.1 Exscientia Company Information
11.2.2 Exscientia AI-assisted Drug Design (AIDD) Product Offered
11.2.3 Exscientia AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Exscientia Main Business Overview
11.2.5 Exscientia Latest Developments
11.3 Google(Alphabet)
11.3.1 Google(Alphabet) Company Information
11.3.2 Google(Alphabet) AI-assisted Drug Design (AIDD) Product Offered
11.3.3 Google(Alphabet) AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Google(Alphabet) Main Business Overview
11.3.5 Google(Alphabet) Latest Developments
11.4 Microsoft
11.4.1 Microsoft Company Information
11.4.2 Microsoft AI-assisted Drug Design (AIDD) Product Offered
11.4.3 Microsoft AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Microsoft Main Business Overview
11.4.5 Microsoft Latest Developments
11.5 Atomwise
11.5.1 Atomwise Company Information
11.5.2 Atomwise AI-assisted Drug Design (AIDD) Product Offered
11.5.3 Atomwise AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Atomwise Main Business Overview
11.5.5 Atomwise Latest Developments
11.6 Schrodinger
11.6.1 Schrodinger Company Information
11.6.2 Schrodinger AI-assisted Drug Design (AIDD) Product Offered
11.6.3 Schrodinger AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Schrodinger Main Business Overview
11.6.5 Schrodinger Latest Developments
11.7 Aitia
11.7.1 Aitia Company Information
11.7.2 Aitia AI-assisted Drug Design (AIDD) Product Offered
11.7.3 Aitia AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Aitia Main Business Overview
11.7.5 Aitia Latest Developments
11.8 Insilico Medicine
11.8.1 Insilico Medicine Company Information
11.8.2 Insilico Medicine AI-assisted Drug Design (AIDD) Product Offered
11.8.3 Insilico Medicine AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Insilico Medicine Main Business Overview
11.8.5 Insilico Medicine Latest Developments
11.9 NVIDIA
11.9.1 NVIDIA Company Information
11.9.2 NVIDIA AI-assisted Drug Design (AIDD) Product Offered
11.9.3 NVIDIA AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 NVIDIA Main Business Overview
11.9.5 NVIDIA Latest Developments
11.10 XtalPi
11.10.1 XtalPi Company Information
11.10.2 XtalPi AI-assisted Drug Design (AIDD) Product Offered
11.10.3 XtalPi AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 XtalPi Main Business Overview
11.10.5 XtalPi Latest Developments
11.11 BPGbio
11.11.1 BPGbio Company Information
11.11.2 BPGbio AI-assisted Drug Design (AIDD) Product Offered
11.11.3 BPGbio AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 BPGbio Main Business Overview
11.11.5 BPGbio Latest Developments
11.12 Owkin
11.12.1 Owkin Company Information
11.12.2 Owkin AI-assisted Drug Design (AIDD) Product Offered
11.12.3 Owkin AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Owkin Main Business Overview
11.12.5 Owkin Latest Developments
11.13 CytoReason
11.13.1 CytoReason Company Information
11.13.2 CytoReason AI-assisted Drug Design (AIDD) Product Offered
11.13.3 CytoReason AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 CytoReason Main Business Overview
11.13.5 CytoReason Latest Developments
11.14 Deep Genomics
11.14.1 Deep Genomics Company Information
11.14.2 Deep Genomics AI-assisted Drug Design (AIDD) Product Offered
11.14.3 Deep Genomics AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Deep Genomics Main Business Overview
11.14.5 Deep Genomics Latest Developments
11.15 Cloud Pharmaceuticals
11.15.1 Cloud Pharmaceuticals Company Information
11.15.2 Cloud Pharmaceuticals AI-assisted Drug Design (AIDD) Product Offered
11.15.3 Cloud Pharmaceuticals AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Cloud Pharmaceuticals Main Business Overview
11.15.5 Cloud Pharmaceuticals Latest Developments
11.16 BenevolentAI
11.16.1 BenevolentAI Company Information
11.16.2 BenevolentAI AI-assisted Drug Design (AIDD) Product Offered
11.16.3 BenevolentAI AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 BenevolentAI Main Business Overview
11.16.5 BenevolentAI Latest Developments
11.17 Cyclica
11.17.1 Cyclica Company Information
11.17.2 Cyclica AI-assisted Drug Design (AIDD) Product Offered
11.17.3 Cyclica AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Cyclica Main Business Overview
11.17.5 Cyclica Latest Developments
11.18 Verge Genomics
11.18.1 Verge Genomics Company Information
11.18.2 Verge Genomics AI-assisted Drug Design (AIDD) Product Offered
11.18.3 Verge Genomics AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Verge Genomics Main Business Overview
11.18.5 Verge Genomics Latest Developments
11.19 Valo Health
11.19.1 Valo Health Company Information
11.19.2 Valo Health AI-assisted Drug Design (AIDD) Product Offered
11.19.3 Valo Health AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 Valo Health Main Business Overview
11.19.5 Valo Health Latest Developments
11.20 Envisagenics
11.20.1 Envisagenics Company Information
11.20.2 Envisagenics AI-assisted Drug Design (AIDD) Product Offered
11.20.3 Envisagenics AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 Envisagenics Main Business Overview
11.20.5 Envisagenics Latest Developments
11.21 Euretos
11.21.1 Euretos Company Information
11.21.2 Euretos AI-assisted Drug Design (AIDD) Product Offered
11.21.3 Euretos AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
11.21.4 Euretos Main Business Overview
11.21.5 Euretos Latest Developments
11.22 BioAge Labs
11.22.1 BioAge Labs Company Information
11.22.2 BioAge Labs AI-assisted Drug Design (AIDD) Product Offered
11.22.3 BioAge Labs AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
11.22.4 BioAge Labs Main Business Overview
11.22.5 BioAge Labs Latest Developments
11.23 Iktos
11.23.1 Iktos Company Information
11.23.2 Iktos AI-assisted Drug Design (AIDD) Product Offered
11.23.3 Iktos AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
11.23.4 Iktos Main Business Overview
11.23.5 Iktos Latest Developments
11.24 BioSymetrics
11.24.1 BioSymetrics Company Information
11.24.2 BioSymetrics AI-assisted Drug Design (AIDD) Product Offered
11.24.3 BioSymetrics AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
11.24.4 BioSymetrics Main Business Overview
11.24.5 BioSymetrics Latest Developments
11.25 Evaxion Biotech
11.25.1 Evaxion Biotech Company Information
11.25.2 Evaxion Biotech AI-assisted Drug Design (AIDD) Product Offered
11.25.3 Evaxion Biotech AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
11.25.4 Evaxion Biotech Main Business Overview
11.25.5 Evaxion Biotech Latest Developments
11.26 Aria Pharmaceuticals
11.26.1 Aria Pharmaceuticals Company Information
11.26.2 Aria Pharmaceuticals AI-assisted Drug Design (AIDD) Product Offered
11.26.3 Aria Pharmaceuticals AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
11.26.4 Aria Pharmaceuticals Main Business Overview
11.26.5 Aria Pharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. AI-assisted Drug Design (AIDD) Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Hardware
Table 3. Major Players of Software
Table 4. Major Players of Service
Table 5. AI-assisted Drug Design (AIDD) Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global AI-assisted Drug Design (AIDD) Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global AI-assisted Drug Design (AIDD) Market Size Market Share by Type (2018-2023)
Table 8. AI-assisted Drug Design (AIDD) Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global AI-assisted Drug Design (AIDD) Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global AI-assisted Drug Design (AIDD) Market Size Market Share by Application (2018-2023)
Table 11. Global AI-assisted Drug Design (AIDD) Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global AI-assisted Drug Design (AIDD) Revenue Market Share by Player (2018-2023)
Table 13. AI-assisted Drug Design (AIDD) Key Players Head office and Products Offered
Table 14. AI-assisted Drug Design (AIDD) Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global AI-assisted Drug Design (AIDD) Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global AI-assisted Drug Design (AIDD) Market Size Market Share by Regions (2018-2023)
Table 19. Global AI-assisted Drug Design (AIDD) Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global AI-assisted Drug Design (AIDD) Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas AI-assisted Drug Design (AIDD) Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas AI-assisted Drug Design (AIDD) Market Size Market Share by Country (2018-2023)
Table 23. Americas AI-assisted Drug Design (AIDD) Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas AI-assisted Drug Design (AIDD) Market Size Market Share by Type (2018-2023)
Table 25. Americas AI-assisted Drug Design (AIDD) Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas AI-assisted Drug Design (AIDD) Market Size Market Share by Application (2018-2023)
Table 27. APAC AI-assisted Drug Design (AIDD) Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC AI-assisted Drug Design (AIDD) Market Size Market Share by Region (2018-2023)
Table 29. APAC AI-assisted Drug Design (AIDD) Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC AI-assisted Drug Design (AIDD) Market Size Market Share by Type (2018-2023)
Table 31. APAC AI-assisted Drug Design (AIDD) Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC AI-assisted Drug Design (AIDD) Market Size Market Share by Application (2018-2023)
Table 33. Europe AI-assisted Drug Design (AIDD) Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe AI-assisted Drug Design (AIDD) Market Size Market Share by Country (2018-2023)
Table 35. Europe AI-assisted Drug Design (AIDD) Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe AI-assisted Drug Design (AIDD) Market Size Market Share by Type (2018-2023)
Table 37. Europe AI-assisted Drug Design (AIDD) Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe AI-assisted Drug Design (AIDD) Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa AI-assisted Drug Design (AIDD) Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa AI-assisted Drug Design (AIDD) Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa AI-assisted Drug Design (AIDD) Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa AI-assisted Drug Design (AIDD) Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa AI-assisted Drug Design (AIDD) Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa AI-assisted Drug Design (AIDD) Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of AI-assisted Drug Design (AIDD)
Table 46. Key Market Challenges & Risks of AI-assisted Drug Design (AIDD)
Table 47. Key Industry Trends of AI-assisted Drug Design (AIDD)
Table 48. Global AI-assisted Drug Design (AIDD) Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global AI-assisted Drug Design (AIDD) Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global AI-assisted Drug Design (AIDD) Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global AI-assisted Drug Design (AIDD) Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. IBM Details, Company Type, AI-assisted Drug Design (AIDD) Area Served and Its Competitors
Table 53. IBM AI-assisted Drug Design (AIDD) Product Offered
Table 54. IBM AI-assisted Drug Design (AIDD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. IBM Main Business
Table 56. IBM Latest Developments
Table 57. Exscientia Details, Company Type, AI-assisted Drug Design (AIDD) Area Served and Its Competitors
Table 58. Exscientia AI-assisted Drug Design (AIDD) Product Offered
Table 59. Exscientia Main Business
Table 60. Exscientia AI-assisted Drug Design (AIDD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Exscientia Latest Developments
Table 62. Google(Alphabet) Details, Company Type, AI-assisted Drug Design (AIDD) Area Served and Its Competitors
Table 63. Google(Alphabet) AI-assisted Drug Design (AIDD) Product Offered
Table 64. Google(Alphabet) Main Business
Table 65. Google(Alphabet) AI-assisted Drug Design (AIDD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Google(Alphabet) Latest Developments
Table 67. Microsoft Details, Company Type, AI-assisted Drug Design (AIDD) Area Served and Its Competitors
Table 68. Microsoft AI-assisted Drug Design (AIDD) Product Offered
Table 69. Microsoft Main Business
Table 70. Microsoft AI-assisted Drug Design (AIDD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Microsoft Latest Developments
Table 72. Atomwise Details, Company Type, AI-assisted Drug Design (AIDD) Area Served and Its Competitors
Table 73. Atomwise AI-assisted Drug Design (AIDD) Product Offered
Table 74. Atomwise Main Business
Table 75. Atomwise AI-assisted Drug Design (AIDD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Atomwise Latest Developments
Table 77. Schrodinger Details, Company Type, AI-assisted Drug Design (AIDD) Area Served and Its Competitors
Table 78. Schrodinger AI-assisted Drug Design (AIDD) Product Offered
Table 79. Schrodinger Main Business
Table 80. Schrodinger AI-assisted Drug Design (AIDD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Schrodinger Latest Developments
Table 82. Aitia Details, Company Type, AI-assisted Drug Design (AIDD) Area Served and Its Competitors
Table 83. Aitia AI-assisted Drug Design (AIDD) Product Offered
Table 84. Aitia Main Business
Table 85. Aitia AI-assisted Drug Design (AIDD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Aitia Latest Developments
Table 87. Insilico Medicine Details, Company Type, AI-assisted Drug Design (AIDD) Area Served and Its Competitors
Table 88. Insilico Medicine AI-assisted Drug Design (AIDD) Product Offered
Table 89. Insilico Medicine Main Business
Table 90. Insilico Medicine AI-assisted Drug Design (AIDD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Insilico Medicine Latest Developments
Table 92. NVIDIA Details, Company Type, AI-assisted Drug Design (AIDD) Area Served and Its Competitors
Table 93. NVIDIA AI-assisted Drug Design (AIDD) Product Offered
Table 94. NVIDIA Main Business
Table 95. NVIDIA AI-assisted Drug Design (AIDD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. NVIDIA Latest Developments
Table 97. XtalPi Details, Company Type, AI-assisted Drug Design (AIDD) Area Served and Its Competitors
Table 98. XtalPi AI-assisted Drug Design (AIDD) Product Offered
Table 99. XtalPi Main Business
Table 100. XtalPi AI-assisted Drug Design (AIDD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. XtalPi Latest Developments
Table 102. BPGbio Details, Company Type, AI-assisted Drug Design (AIDD) Area Served and Its Competitors
Table 103. BPGbio AI-assisted Drug Design (AIDD) Product Offered
Table 104. BPGbio AI-assisted Drug Design (AIDD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. BPGbio Main Business
Table 106. BPGbio Latest Developments
Table 107. Owkin Details, Company Type, AI-assisted Drug Design (AIDD) Area Served and Its Competitors
Table 108. Owkin AI-assisted Drug Design (AIDD) Product Offered
Table 109. Owkin Main Business
Table 110. Owkin AI-assisted Drug Design (AIDD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. Owkin Latest Developments
Table 112. CytoReason Details, Company Type, AI-assisted Drug Design (AIDD) Area Served and Its Competitors
Table 113. CytoReason AI-assisted Drug Design (AIDD) Product Offered
Table 114. CytoReason Main Business
Table 115. CytoReason AI-assisted Drug Design (AIDD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. CytoReason Latest Developments
Table 117. Deep Genomics Details, Company Type, AI-assisted Drug Design (AIDD) Area Served and Its Competitors
Table 118. Deep Genomics AI-assisted Drug Design (AIDD) Product Offered
Table 119. Deep Genomics Main Business
Table 120. Deep Genomics AI-assisted Drug Design (AIDD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 121. Deep Genomics Latest Developments
Table 122. Cloud Pharmaceuticals Details, Company Type, AI-assisted Drug Design (AIDD) Area Served and Its Competitors
Table 123. Cloud Pharmaceuticals AI-assisted Drug Design (AIDD) Product Offered
Table 124. Cloud Pharmaceuticals Main Business
Table 125. Cloud Pharmaceuticals AI-assisted Drug Design (AIDD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 126. Cloud Pharmaceuticals Latest Developments
Table 127. BenevolentAI Details, Company Type, AI-assisted Drug Design (AIDD) Area Served and Its Competitors
Table 128. BenevolentAI AI-assisted Drug Design (AIDD) Product Offered
Table 129. BenevolentAI Main Business
Table 130. BenevolentAI AI-assisted Drug Design (AIDD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 131. BenevolentAI Latest Developments
Table 132. Cyclica Details, Company Type, AI-assisted Drug Design (AIDD) Area Served and Its Competitors
Table 133. Cyclica AI-assisted Drug Design (AIDD) Product Offered
Table 134. Cyclica Main Business
Table 135. Cyclica AI-assisted Drug Design (AIDD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 136. Cyclica Latest Developments
Table 137. Verge Genomics Details, Company Type, AI-assisted Drug Design (AIDD) Area Served and Its Competitors
Table 138. Verge Genomics AI-assisted Drug Design (AIDD) Product Offered
Table 139. Verge Genomics Main Business
Table 140. Verge Genomics AI-assisted Drug Design (AIDD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 141. Verge Genomics Latest Developments
Table 142. Valo Health Details, Company Type, AI-assisted Drug Design (AIDD) Area Served and Its Competitors
Table 143. Valo Health AI-assisted Drug Design (AIDD) Product Offered
Table 144. Valo Health Main Business
Table 145. Valo Health AI-assisted Drug Design (AIDD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 146. Valo Health Latest Developments
Table 147. Envisagenics Details, Company Type, AI-assisted Drug Design (AIDD) Area Served and Its Competitors
Table 148. Envisagenics AI-assisted Drug Design (AIDD) Product Offered
Table 149. Envisagenics Main Business
Table 150. Envisagenics AI-assisted Drug Design (AIDD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 151. Envisagenics Latest Developments
Table 152. Euretos Details, Company Type, AI-assisted Drug Design (AIDD) Area Served and Its Competitors
Table 153. Euretos AI-assisted Drug Design (AIDD) Product Offered
Table 154. Euretos AI-assisted Drug Design (AIDD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 155. Euretos Main Business
Table 156. Euretos Latest Developments
Table 157. BioAge Labs Details, Company Type, AI-assisted Drug Design (AIDD) Area Served and Its Competitors
Table 158. BioAge Labs AI-assisted Drug Design (AIDD) Product Offered
Table 159. BioAge Labs Main Business
Table 160. BioAge Labs AI-assisted Drug Design (AIDD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 161. BioAge Labs Latest Developments
Table 162. Iktos Details, Company Type, AI-assisted Drug Design (AIDD) Area Served and Its Competitors
Table 163. Iktos AI-assisted Drug Design (AIDD) Product Offered
Table 164. Iktos Main Business
Table 165. Iktos AI-assisted Drug Design (AIDD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 166. Iktos Latest Developments
Table 167. BioSymetrics Details, Company Type, AI-assisted Drug Design (AIDD) Area Served and Its Competitors
Table 168. BioSymetrics AI-assisted Drug Design (AIDD) Product Offered
Table 169. BioSymetrics Main Business
Table 170. BioSymetrics AI-assisted Drug Design (AIDD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 171. BioSymetrics Latest Developments
Table 172. Evaxion Biotech Details, Company Type, AI-assisted Drug Design (AIDD) Area Served and Its Competitors
Table 173. Evaxion Biotech AI-assisted Drug Design (AIDD) Product Offered
Table 174. Evaxion Biotech Main Business
Table 175. Evaxion Biotech AI-assisted Drug Design (AIDD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 176. Evaxion Biotech Latest Developments
Table 177. Aria Pharmaceuticals Details, Company Type, AI-assisted Drug Design (AIDD) Area Served and Its Competitors
Table 178. Aria Pharmaceuticals AI-assisted Drug Design (AIDD) Product Offered
Table 179. Aria Pharmaceuticals Main Business
Table 180. Aria Pharmaceuticals AI-assisted Drug Design (AIDD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 181. Aria Pharmaceuticals Latest Developments
Table 1. AI-assisted Drug Design (AIDD) Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Hardware
Table 3. Major Players of Software
Table 4. Major Players of Service
Table 5. AI-assisted Drug Design (AIDD) Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global AI-assisted Drug Design (AIDD) Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global AI-assisted Drug Design (AIDD) Market Size Market Share by Type (2018-2023)
Table 8. AI-assisted Drug Design (AIDD) Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global AI-assisted Drug Design (AIDD) Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global AI-assisted Drug Design (AIDD) Market Size Market Share by Application (2018-2023)
Table 11. Global AI-assisted Drug Design (AIDD) Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global AI-assisted Drug Design (AIDD) Revenue Market Share by Player (2018-2023)
Table 13. AI-assisted Drug Design (AIDD) Key Players Head office and Products Offered
Table 14. AI-assisted Drug Design (AIDD) Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global AI-assisted Drug Design (AIDD) Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global AI-assisted Drug Design (AIDD) Market Size Market Share by Regions (2018-2023)
Table 19. Global AI-assisted Drug Design (AIDD) Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global AI-assisted Drug Design (AIDD) Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas AI-assisted Drug Design (AIDD) Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas AI-assisted Drug Design (AIDD) Market Size Market Share by Country (2018-2023)
Table 23. Americas AI-assisted Drug Design (AIDD) Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas AI-assisted Drug Design (AIDD) Market Size Market Share by Type (2018-2023)
Table 25. Americas AI-assisted Drug Design (AIDD) Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas AI-assisted Drug Design (AIDD) Market Size Market Share by Application (2018-2023)
Table 27. APAC AI-assisted Drug Design (AIDD) Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC AI-assisted Drug Design (AIDD) Market Size Market Share by Region (2018-2023)
Table 29. APAC AI-assisted Drug Design (AIDD) Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC AI-assisted Drug Design (AIDD) Market Size Market Share by Type (2018-2023)
Table 31. APAC AI-assisted Drug Design (AIDD) Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC AI-assisted Drug Design (AIDD) Market Size Market Share by Application (2018-2023)
Table 33. Europe AI-assisted Drug Design (AIDD) Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe AI-assisted Drug Design (AIDD) Market Size Market Share by Country (2018-2023)
Table 35. Europe AI-assisted Drug Design (AIDD) Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe AI-assisted Drug Design (AIDD) Market Size Market Share by Type (2018-2023)
Table 37. Europe AI-assisted Drug Design (AIDD) Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe AI-assisted Drug Design (AIDD) Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa AI-assisted Drug Design (AIDD) Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa AI-assisted Drug Design (AIDD) Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa AI-assisted Drug Design (AIDD) Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa AI-assisted Drug Design (AIDD) Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa AI-assisted Drug Design (AIDD) Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa AI-assisted Drug Design (AIDD) Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of AI-assisted Drug Design (AIDD)
Table 46. Key Market Challenges & Risks of AI-assisted Drug Design (AIDD)
Table 47. Key Industry Trends of AI-assisted Drug Design (AIDD)
Table 48. Global AI-assisted Drug Design (AIDD) Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global AI-assisted Drug Design (AIDD) Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global AI-assisted Drug Design (AIDD) Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global AI-assisted Drug Design (AIDD) Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. IBM Details, Company Type, AI-assisted Drug Design (AIDD) Area Served and Its Competitors
Table 53. IBM AI-assisted Drug Design (AIDD) Product Offered
Table 54. IBM AI-assisted Drug Design (AIDD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. IBM Main Business
Table 56. IBM Latest Developments
Table 57. Exscientia Details, Company Type, AI-assisted Drug Design (AIDD) Area Served and Its Competitors
Table 58. Exscientia AI-assisted Drug Design (AIDD) Product Offered
Table 59. Exscientia Main Business
Table 60. Exscientia AI-assisted Drug Design (AIDD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Exscientia Latest Developments
Table 62. Google(Alphabet) Details, Company Type, AI-assisted Drug Design (AIDD) Area Served and Its Competitors
Table 63. Google(Alphabet) AI-assisted Drug Design (AIDD) Product Offered
Table 64. Google(Alphabet) Main Business
Table 65. Google(Alphabet) AI-assisted Drug Design (AIDD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Google(Alphabet) Latest Developments
Table 67. Microsoft Details, Company Type, AI-assisted Drug Design (AIDD) Area Served and Its Competitors
Table 68. Microsoft AI-assisted Drug Design (AIDD) Product Offered
Table 69. Microsoft Main Business
Table 70. Microsoft AI-assisted Drug Design (AIDD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Microsoft Latest Developments
Table 72. Atomwise Details, Company Type, AI-assisted Drug Design (AIDD) Area Served and Its Competitors
Table 73. Atomwise AI-assisted Drug Design (AIDD) Product Offered
Table 74. Atomwise Main Business
Table 75. Atomwise AI-assisted Drug Design (AIDD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Atomwise Latest Developments
Table 77. Schrodinger Details, Company Type, AI-assisted Drug Design (AIDD) Area Served and Its Competitors
Table 78. Schrodinger AI-assisted Drug Design (AIDD) Product Offered
Table 79. Schrodinger Main Business
Table 80. Schrodinger AI-assisted Drug Design (AIDD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Schrodinger Latest Developments
Table 82. Aitia Details, Company Type, AI-assisted Drug Design (AIDD) Area Served and Its Competitors
Table 83. Aitia AI-assisted Drug Design (AIDD) Product Offered
Table 84. Aitia Main Business
Table 85. Aitia AI-assisted Drug Design (AIDD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Aitia Latest Developments
Table 87. Insilico Medicine Details, Company Type, AI-assisted Drug Design (AIDD) Area Served and Its Competitors
Table 88. Insilico Medicine AI-assisted Drug Design (AIDD) Product Offered
Table 89. Insilico Medicine Main Business
Table 90. Insilico Medicine AI-assisted Drug Design (AIDD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Insilico Medicine Latest Developments
Table 92. NVIDIA Details, Company Type, AI-assisted Drug Design (AIDD) Area Served and Its Competitors
Table 93. NVIDIA AI-assisted Drug Design (AIDD) Product Offered
Table 94. NVIDIA Main Business
Table 95. NVIDIA AI-assisted Drug Design (AIDD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. NVIDIA Latest Developments
Table 97. XtalPi Details, Company Type, AI-assisted Drug Design (AIDD) Area Served and Its Competitors
Table 98. XtalPi AI-assisted Drug Design (AIDD) Product Offered
Table 99. XtalPi Main Business
Table 100. XtalPi AI-assisted Drug Design (AIDD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. XtalPi Latest Developments
Table 102. BPGbio Details, Company Type, AI-assisted Drug Design (AIDD) Area Served and Its Competitors
Table 103. BPGbio AI-assisted Drug Design (AIDD) Product Offered
Table 104. BPGbio AI-assisted Drug Design (AIDD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. BPGbio Main Business
Table 106. BPGbio Latest Developments
Table 107. Owkin Details, Company Type, AI-assisted Drug Design (AIDD) Area Served and Its Competitors
Table 108. Owkin AI-assisted Drug Design (AIDD) Product Offered
Table 109. Owkin Main Business
Table 110. Owkin AI-assisted Drug Design (AIDD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. Owkin Latest Developments
Table 112. CytoReason Details, Company Type, AI-assisted Drug Design (AIDD) Area Served and Its Competitors
Table 113. CytoReason AI-assisted Drug Design (AIDD) Product Offered
Table 114. CytoReason Main Business
Table 115. CytoReason AI-assisted Drug Design (AIDD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. CytoReason Latest Developments
Table 117. Deep Genomics Details, Company Type, AI-assisted Drug Design (AIDD) Area Served and Its Competitors
Table 118. Deep Genomics AI-assisted Drug Design (AIDD) Product Offered
Table 119. Deep Genomics Main Business
Table 120. Deep Genomics AI-assisted Drug Design (AIDD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 121. Deep Genomics Latest Developments
Table 122. Cloud Pharmaceuticals Details, Company Type, AI-assisted Drug Design (AIDD) Area Served and Its Competitors
Table 123. Cloud Pharmaceuticals AI-assisted Drug Design (AIDD) Product Offered
Table 124. Cloud Pharmaceuticals Main Business
Table 125. Cloud Pharmaceuticals AI-assisted Drug Design (AIDD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 126. Cloud Pharmaceuticals Latest Developments
Table 127. BenevolentAI Details, Company Type, AI-assisted Drug Design (AIDD) Area Served and Its Competitors
Table 128. BenevolentAI AI-assisted Drug Design (AIDD) Product Offered
Table 129. BenevolentAI Main Business
Table 130. BenevolentAI AI-assisted Drug Design (AIDD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 131. BenevolentAI Latest Developments
Table 132. Cyclica Details, Company Type, AI-assisted Drug Design (AIDD) Area Served and Its Competitors
Table 133. Cyclica AI-assisted Drug Design (AIDD) Product Offered
Table 134. Cyclica Main Business
Table 135. Cyclica AI-assisted Drug Design (AIDD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 136. Cyclica Latest Developments
Table 137. Verge Genomics Details, Company Type, AI-assisted Drug Design (AIDD) Area Served and Its Competitors
Table 138. Verge Genomics AI-assisted Drug Design (AIDD) Product Offered
Table 139. Verge Genomics Main Business
Table 140. Verge Genomics AI-assisted Drug Design (AIDD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 141. Verge Genomics Latest Developments
Table 142. Valo Health Details, Company Type, AI-assisted Drug Design (AIDD) Area Served and Its Competitors
Table 143. Valo Health AI-assisted Drug Design (AIDD) Product Offered
Table 144. Valo Health Main Business
Table 145. Valo Health AI-assisted Drug Design (AIDD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 146. Valo Health Latest Developments
Table 147. Envisagenics Details, Company Type, AI-assisted Drug Design (AIDD) Area Served and Its Competitors
Table 148. Envisagenics AI-assisted Drug Design (AIDD) Product Offered
Table 149. Envisagenics Main Business
Table 150. Envisagenics AI-assisted Drug Design (AIDD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 151. Envisagenics Latest Developments
Table 152. Euretos Details, Company Type, AI-assisted Drug Design (AIDD) Area Served and Its Competitors
Table 153. Euretos AI-assisted Drug Design (AIDD) Product Offered
Table 154. Euretos AI-assisted Drug Design (AIDD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 155. Euretos Main Business
Table 156. Euretos Latest Developments
Table 157. BioAge Labs Details, Company Type, AI-assisted Drug Design (AIDD) Area Served and Its Competitors
Table 158. BioAge Labs AI-assisted Drug Design (AIDD) Product Offered
Table 159. BioAge Labs Main Business
Table 160. BioAge Labs AI-assisted Drug Design (AIDD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 161. BioAge Labs Latest Developments
Table 162. Iktos Details, Company Type, AI-assisted Drug Design (AIDD) Area Served and Its Competitors
Table 163. Iktos AI-assisted Drug Design (AIDD) Product Offered
Table 164. Iktos Main Business
Table 165. Iktos AI-assisted Drug Design (AIDD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 166. Iktos Latest Developments
Table 167. BioSymetrics Details, Company Type, AI-assisted Drug Design (AIDD) Area Served and Its Competitors
Table 168. BioSymetrics AI-assisted Drug Design (AIDD) Product Offered
Table 169. BioSymetrics Main Business
Table 170. BioSymetrics AI-assisted Drug Design (AIDD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 171. BioSymetrics Latest Developments
Table 172. Evaxion Biotech Details, Company Type, AI-assisted Drug Design (AIDD) Area Served and Its Competitors
Table 173. Evaxion Biotech AI-assisted Drug Design (AIDD) Product Offered
Table 174. Evaxion Biotech Main Business
Table 175. Evaxion Biotech AI-assisted Drug Design (AIDD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 176. Evaxion Biotech Latest Developments
Table 177. Aria Pharmaceuticals Details, Company Type, AI-assisted Drug Design (AIDD) Area Served and Its Competitors
Table 178. Aria Pharmaceuticals AI-assisted Drug Design (AIDD) Product Offered
Table 179. Aria Pharmaceuticals Main Business
Table 180. Aria Pharmaceuticals AI-assisted Drug Design (AIDD) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 181. Aria Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. AI-assisted Drug Design (AIDD) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global AI-assisted Drug Design (AIDD) Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. AI-assisted Drug Design (AIDD) Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. AI-assisted Drug Design (AIDD) Sales Market Share by Country/Region (2022)
Figure 8. AI-assisted Drug Design (AIDD) Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global AI-assisted Drug Design (AIDD) Market Size Market Share by Type in 2022
Figure 10. AI-assisted Drug Design (AIDD) in Early Drug Discovery
Figure 11. Global AI-assisted Drug Design (AIDD) Market: Early Drug Discovery (2018-2023) & ($ Millions)
Figure 12. AI-assisted Drug Design (AIDD) in Preclinical Phase
Figure 13. Global AI-assisted Drug Design (AIDD) Market: Preclinical Phase (2018-2023) & ($ Millions)
Figure 14. AI-assisted Drug Design (AIDD) in Clinical Phase
Figure 15. Global AI-assisted Drug Design (AIDD) Market: Clinical Phase (2018-2023) & ($ Millions)
Figure 16. AI-assisted Drug Design (AIDD) in Regulatory Approval
Figure 17. Global AI-assisted Drug Design (AIDD) Market: Regulatory Approval (2018-2023) & ($ Millions)
Figure 18. Global AI-assisted Drug Design (AIDD) Market Size Market Share by Application in 2022
Figure 19. Global AI-assisted Drug Design (AIDD) Revenue Market Share by Player in 2022
Figure 20. Global AI-assisted Drug Design (AIDD) Market Size Market Share by Regions (2018-2023)
Figure 21. Americas AI-assisted Drug Design (AIDD) Market Size 2018-2023 ($ Millions)
Figure 22. APAC AI-assisted Drug Design (AIDD) Market Size 2018-2023 ($ Millions)
Figure 23. Europe AI-assisted Drug Design (AIDD) Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa AI-assisted Drug Design (AIDD) Market Size 2018-2023 ($ Millions)
Figure 25. Americas AI-assisted Drug Design (AIDD) Value Market Share by Country in 2022
Figure 26. United States AI-assisted Drug Design (AIDD) Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada AI-assisted Drug Design (AIDD) Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico AI-assisted Drug Design (AIDD) Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil AI-assisted Drug Design (AIDD) Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC AI-assisted Drug Design (AIDD) Market Size Market Share by Region in 2022
Figure 31. APAC AI-assisted Drug Design (AIDD) Market Size Market Share by Type in 2022
Figure 32. APAC AI-assisted Drug Design (AIDD) Market Size Market Share by Application in 2022
Figure 33. China AI-assisted Drug Design (AIDD) Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan AI-assisted Drug Design (AIDD) Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea AI-assisted Drug Design (AIDD) Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia AI-assisted Drug Design (AIDD) Market Size Growth 2018-2023 ($ Millions)
Figure 37. India AI-assisted Drug Design (AIDD) Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia AI-assisted Drug Design (AIDD) Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe AI-assisted Drug Design (AIDD) Market Size Market Share by Country in 2022
Figure 40. Europe AI-assisted Drug Design (AIDD) Market Size Market Share by Type (2018-2023)
Figure 41. Europe AI-assisted Drug Design (AIDD) Market Size Market Share by Application (2018-2023)
Figure 42. Germany AI-assisted Drug Design (AIDD) Market Size Growth 2018-2023 ($ Millions)
Figure 43. France AI-assisted Drug Design (AIDD) Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK AI-assisted Drug Design (AIDD) Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy AI-assisted Drug Design (AIDD) Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia AI-assisted Drug Design (AIDD) Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa AI-assisted Drug Design (AIDD) Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa AI-assisted Drug Design (AIDD) Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa AI-assisted Drug Design (AIDD) Market Size Market Share by Application (2018-2023)
Figure 50. Egypt AI-assisted Drug Design (AIDD) Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa AI-assisted Drug Design (AIDD) Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel AI-assisted Drug Design (AIDD) Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey AI-assisted Drug Design (AIDD) Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country AI-assisted Drug Design (AIDD) Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas AI-assisted Drug Design (AIDD) Market Size 2024-2029 ($ Millions)
Figure 56. APAC AI-assisted Drug Design (AIDD) Market Size 2024-2029 ($ Millions)
Figure 57. Europe AI-assisted Drug Design (AIDD) Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa AI-assisted Drug Design (AIDD) Market Size 2024-2029 ($ Millions)
Figure 59. United States AI-assisted Drug Design (AIDD) Market Size 2024-2029 ($ Millions)
Figure 60. Canada AI-assisted Drug Design (AIDD) Market Size 2024-2029 ($ Millions)
Figure 61. Mexico AI-assisted Drug Design (AIDD) Market Size 2024-2029 ($ Millions)
Figure 62. Brazil AI-assisted Drug Design (AIDD) Market Size 2024-2029 ($ Millions)
Figure 63. China AI-assisted Drug Design (AIDD) Market Size 2024-2029 ($ Millions)
Figure 64. Japan AI-assisted Drug Design (AIDD) Market Size 2024-2029 ($ Millions)
Figure 65. Korea AI-assisted Drug Design (AIDD) Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia AI-assisted Drug Design (AIDD) Market Size 2024-2029 ($ Millions)
Figure 67. India AI-assisted Drug Design (AIDD) Market Size 2024-2029 ($ Millions)
Figure 68. Australia AI-assisted Drug Design (AIDD) Market Size 2024-2029 ($ Millions)
Figure 69. Germany AI-assisted Drug Design (AIDD) Market Size 2024-2029 ($ Millions)
Figure 70. France AI-assisted Drug Design (AIDD) Market Size 2024-2029 ($ Millions)
Figure 71. UK AI-assisted Drug Design (AIDD) Market Size 2024-2029 ($ Millions)
Figure 72. Italy AI-assisted Drug Design (AIDD) Market Size 2024-2029 ($ Millions)
Figure 73. Russia AI-assisted Drug Design (AIDD) Market Size 2024-2029 ($ Millions)
Figure 74. Spain AI-assisted Drug Design (AIDD) Market Size 2024-2029 ($ Millions)
Figure 75. Egypt AI-assisted Drug Design (AIDD) Market Size 2024-2029 ($ Millions)
Figure 76. South Africa AI-assisted Drug Design (AIDD) Market Size 2024-2029 ($ Millions)
Figure 77. Israel AI-assisted Drug Design (AIDD) Market Size 2024-2029 ($ Millions)
Figure 78. Turkey AI-assisted Drug Design (AIDD) Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries AI-assisted Drug Design (AIDD) Market Size 2024-2029 ($ Millions)
Figure 80. Global AI-assisted Drug Design (AIDD) Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global AI-assisted Drug Design (AIDD) Market Size Market Share Forecast by Application (2024-2029)
Figure 1. AI-assisted Drug Design (AIDD) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global AI-assisted Drug Design (AIDD) Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. AI-assisted Drug Design (AIDD) Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. AI-assisted Drug Design (AIDD) Sales Market Share by Country/Region (2022)
Figure 8. AI-assisted Drug Design (AIDD) Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global AI-assisted Drug Design (AIDD) Market Size Market Share by Type in 2022
Figure 10. AI-assisted Drug Design (AIDD) in Early Drug Discovery
Figure 11. Global AI-assisted Drug Design (AIDD) Market: Early Drug Discovery (2018-2023) & ($ Millions)
Figure 12. AI-assisted Drug Design (AIDD) in Preclinical Phase
Figure 13. Global AI-assisted Drug Design (AIDD) Market: Preclinical Phase (2018-2023) & ($ Millions)
Figure 14. AI-assisted Drug Design (AIDD) in Clinical Phase
Figure 15. Global AI-assisted Drug Design (AIDD) Market: Clinical Phase (2018-2023) & ($ Millions)
Figure 16. AI-assisted Drug Design (AIDD) in Regulatory Approval
Figure 17. Global AI-assisted Drug Design (AIDD) Market: Regulatory Approval (2018-2023) & ($ Millions)
Figure 18. Global AI-assisted Drug Design (AIDD) Market Size Market Share by Application in 2022
Figure 19. Global AI-assisted Drug Design (AIDD) Revenue Market Share by Player in 2022
Figure 20. Global AI-assisted Drug Design (AIDD) Market Size Market Share by Regions (2018-2023)
Figure 21. Americas AI-assisted Drug Design (AIDD) Market Size 2018-2023 ($ Millions)
Figure 22. APAC AI-assisted Drug Design (AIDD) Market Size 2018-2023 ($ Millions)
Figure 23. Europe AI-assisted Drug Design (AIDD) Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa AI-assisted Drug Design (AIDD) Market Size 2018-2023 ($ Millions)
Figure 25. Americas AI-assisted Drug Design (AIDD) Value Market Share by Country in 2022
Figure 26. United States AI-assisted Drug Design (AIDD) Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada AI-assisted Drug Design (AIDD) Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico AI-assisted Drug Design (AIDD) Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil AI-assisted Drug Design (AIDD) Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC AI-assisted Drug Design (AIDD) Market Size Market Share by Region in 2022
Figure 31. APAC AI-assisted Drug Design (AIDD) Market Size Market Share by Type in 2022
Figure 32. APAC AI-assisted Drug Design (AIDD) Market Size Market Share by Application in 2022
Figure 33. China AI-assisted Drug Design (AIDD) Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan AI-assisted Drug Design (AIDD) Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea AI-assisted Drug Design (AIDD) Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia AI-assisted Drug Design (AIDD) Market Size Growth 2018-2023 ($ Millions)
Figure 37. India AI-assisted Drug Design (AIDD) Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia AI-assisted Drug Design (AIDD) Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe AI-assisted Drug Design (AIDD) Market Size Market Share by Country in 2022
Figure 40. Europe AI-assisted Drug Design (AIDD) Market Size Market Share by Type (2018-2023)
Figure 41. Europe AI-assisted Drug Design (AIDD) Market Size Market Share by Application (2018-2023)
Figure 42. Germany AI-assisted Drug Design (AIDD) Market Size Growth 2018-2023 ($ Millions)
Figure 43. France AI-assisted Drug Design (AIDD) Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK AI-assisted Drug Design (AIDD) Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy AI-assisted Drug Design (AIDD) Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia AI-assisted Drug Design (AIDD) Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa AI-assisted Drug Design (AIDD) Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa AI-assisted Drug Design (AIDD) Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa AI-assisted Drug Design (AIDD) Market Size Market Share by Application (2018-2023)
Figure 50. Egypt AI-assisted Drug Design (AIDD) Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa AI-assisted Drug Design (AIDD) Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel AI-assisted Drug Design (AIDD) Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey AI-assisted Drug Design (AIDD) Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country AI-assisted Drug Design (AIDD) Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas AI-assisted Drug Design (AIDD) Market Size 2024-2029 ($ Millions)
Figure 56. APAC AI-assisted Drug Design (AIDD) Market Size 2024-2029 ($ Millions)
Figure 57. Europe AI-assisted Drug Design (AIDD) Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa AI-assisted Drug Design (AIDD) Market Size 2024-2029 ($ Millions)
Figure 59. United States AI-assisted Drug Design (AIDD) Market Size 2024-2029 ($ Millions)
Figure 60. Canada AI-assisted Drug Design (AIDD) Market Size 2024-2029 ($ Millions)
Figure 61. Mexico AI-assisted Drug Design (AIDD) Market Size 2024-2029 ($ Millions)
Figure 62. Brazil AI-assisted Drug Design (AIDD) Market Size 2024-2029 ($ Millions)
Figure 63. China AI-assisted Drug Design (AIDD) Market Size 2024-2029 ($ Millions)
Figure 64. Japan AI-assisted Drug Design (AIDD) Market Size 2024-2029 ($ Millions)
Figure 65. Korea AI-assisted Drug Design (AIDD) Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia AI-assisted Drug Design (AIDD) Market Size 2024-2029 ($ Millions)
Figure 67. India AI-assisted Drug Design (AIDD) Market Size 2024-2029 ($ Millions)
Figure 68. Australia AI-assisted Drug Design (AIDD) Market Size 2024-2029 ($ Millions)
Figure 69. Germany AI-assisted Drug Design (AIDD) Market Size 2024-2029 ($ Millions)
Figure 70. France AI-assisted Drug Design (AIDD) Market Size 2024-2029 ($ Millions)
Figure 71. UK AI-assisted Drug Design (AIDD) Market Size 2024-2029 ($ Millions)
Figure 72. Italy AI-assisted Drug Design (AIDD) Market Size 2024-2029 ($ Millions)
Figure 73. Russia AI-assisted Drug Design (AIDD) Market Size 2024-2029 ($ Millions)
Figure 74. Spain AI-assisted Drug Design (AIDD) Market Size 2024-2029 ($ Millions)
Figure 75. Egypt AI-assisted Drug Design (AIDD) Market Size 2024-2029 ($ Millions)
Figure 76. South Africa AI-assisted Drug Design (AIDD) Market Size 2024-2029 ($ Millions)
Figure 77. Israel AI-assisted Drug Design (AIDD) Market Size 2024-2029 ($ Millions)
Figure 78. Turkey AI-assisted Drug Design (AIDD) Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries AI-assisted Drug Design (AIDD) Market Size 2024-2029 ($ Millions)
Figure 80. Global AI-assisted Drug Design (AIDD) Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global AI-assisted Drug Design (AIDD) Market Size Market Share Forecast by Application (2024-2029)
